Cota, Inc., a Hackensack, New Jersey-based platform to deliver real-time clinical outcomes data and cost analysis for cancer care, raised $3.7m of a $7m Series A funding round.
The round was led by Horizon Healthcare Services, Inc. with participation from Med-Metrix. As part of the funding, Dr. Glenn D. Pomerantz, JD, Vice President and Chief Medical Officer of Horizon Healthcare Services, Inc., Joseph Davi, CEO of Med-Metrix and Dr. William T. DeRosa of the Regional Cancer Care Associates (RCCA) joined the company’s board of directors. A second appointee from Horizon who will be named at a later date will also join COTA’s board.
The company intends to use the funds to expand development of the COTA platform, hire biostatisticians, outcome analysts, data support as well as sales and marketing personnel to help launch the first commercial product.
Led by Andrew Pecora, MD, Executive Chairman and Founder, Cota aims to enable optimal care for every cancer patient by generating actionable, real-time via a cloud-based platform that enables doctors and health plans to move from fee-for-service to value-based reimbursement models.